{
  "term": "Orencia",
  "role": "concept",
  "parent_concepts": [
    "Immunosuppressive"
  ],
  "layer": 6,
  "domain": "PhysicalWorld",
  "definition": "a fusion protein medication (abatacept) that selectively modulates T-cell activation by binding to CD80 and CD86 on antigen-presenting cells, used primarily to treat rheumatoid arthritis and other autoimmune conditions",
  "aliases": [
    "orencia",
    "abatacept",
    "orencia medication",
    "abatacept injection"
  ],
  "wordnet": {
    "synsets": [
      "orencia.n.01"
    ],
    "canonical_synset": "orencia.n.01",
    "lemmas": [
      "orencia",
      "abatacept",
      "orencia medication",
      "abatacept injection"
    ],
    "pos": "noun"
  },
  "relationships": {
    "related": [],
    "antonyms": [],
    "has_part": [],
    "part_of": []
  },
  "safety_tags": {
    "risk_level": "low",
    "impacts": [],
    "treaty_relevant": false,
    "harness_relevant": false
  },
  "training_hints": {
    "positive_examples": [],
    "negative_examples": [],
    "disambiguation": "",
    "seed_terms": [
      "orencia",
      "abatacept",
      "orencia medication",
      "abatacept injection"
    ]
  },
  "is_category_lens": true,
  "child_count": 0
}